Seğmen Fatih, Aydemir Semih, Küçük Onur, Parpucu Ümit Murat, Dokuyucu Recep
Department of Intensive Care Unit, Ankara City Hospital, 06800 Ankara, Türkiye.
Department of Anesthesiology and Reanimation, Yenimahalle Training and Research Hospital, University of Yıldırım Beyazit, 06760 Ankara, Türkiye.
Curr Issues Mol Biol. 2024 Nov 28;46(12):13554-13564. doi: 10.3390/cimb46120810.
This study aimed to investigate the protective effects of vitamin B complex and alpha-lipoic acid (ALA) pre-treatments on hepatic ischemia-reperfusion injury (IRI) in rats, focusing on their potential to enhance antioxidant defense mechanisms and reduce post-ischemic liver damage. Thirty male Wistar albino rats were divided into four groups: sham group (n = 10), IRI group (n = 10), vitamin B group (n = 10), vitamin B + ALA group (n = 10). In the IRI, vitamin B, and vitamin B + ALA groups, the rats underwent 45 min of hepatic ischemia followed by 60 min of reperfusion. Serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), urea, creatinine, and lactate dehydrogenase (LDH) were measured. Additionally, serum total antioxidant status (TAS) and total oxidant status (TOS) were assessed, and the oxidative stress index (OSI) was calculated. Liver tissue samples were collected for morphological evaluation. In the vitamin B and vitamin B + ALA groups, ALT, AST, urea, creatinine and LDH levels were better compared with the IRI group but the difference was statistically significant for only LDH levels in the vitamin B group and ALT, urea, and LDH levels in the vitamin B + ALA group ( < 0.05). The lowest TOS and OSI levels were reported in the vitamin B and vitamin B + ALA groups and these groups had statistically significantly higher TAS compared with the sham and IRI groups ( < 0.05). Our findings suggest that a vitamin B complex alone or a vitamin B complex + ALA combination reduces post-ischemic hepatic injury by enhancing the anti-oxidative status. The low dose of ALA may be a co-factor in these results and studies with larger doses of ALA are required to determine its effects on IRI of the liver.
本研究旨在探讨复合维生素B和α-硫辛酸(ALA)预处理对大鼠肝脏缺血再灌注损伤(IRI)的保护作用,重点关注其增强抗氧化防御机制和减轻缺血后肝脏损伤的潜力。将30只雄性Wistar白化大鼠分为四组:假手术组(n = 10)、IRI组(n = 10)、维生素B组(n = 10)、维生素B + ALA组(n = 10)。在IRI组、维生素B组和维生素B + ALA组中,大鼠经历45分钟的肝脏缺血,随后再灌注60分钟。检测血清天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、尿素、肌酐和乳酸脱氢酶(LDH)水平。此外,评估血清总抗氧化状态(TAS)和总氧化状态(TOS),并计算氧化应激指数(OSI)。收集肝脏组织样本进行形态学评估。与IRI组相比,维生素B组和维生素B + ALA组的ALT、AST、尿素、肌酐和LDH水平有所改善,但仅维生素B组的LDH水平以及维生素B + ALA组的ALT、尿素和LDH水平差异具有统计学意义(<0.05)。维生素B组和维生素B + ALA组的TOS和OSI水平最低,与假手术组和IRI组相比,这两组的TAS在统计学上显著更高(<0.05)。我们的研究结果表明,单独使用复合维生素B或复合维生素B与ALA联合使用可通过增强抗氧化状态减轻缺血后肝脏损伤。低剂量的ALA可能是这些结果的一个辅助因素,需要进行更大剂量ALA的研究以确定其对肝脏IRI的影响。